vs

Side-by-side financial comparison of Hippo Holdings Inc. (HIPO) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

OPKO HEALTH, INC. is the larger business by last-quarter revenue ($148.5M vs $120.4M, roughly 1.2× Hippo Holdings Inc.). Hippo Holdings Inc. runs the higher net margin — 5.0% vs -21.1%, a 26.0% gap on every dollar of revenue. On growth, Hippo Holdings Inc. posted the faster year-over-year revenue change (18.2% vs -19.2%). Hippo Holdings Inc. produced more free cash flow last quarter ($9.1M vs $-28.6M). Over the past eight quarters, Hippo Holdings Inc.'s revenue compounded faster (18.9% CAGR vs -7.5%).

Hippo Valley Estate is a sugar estate found near the town of Chiredzi in Chiredzi District of southeastern Zimbabwe, on the Runde River near the border with Mozambique.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

HIPO vs OPK — Head-to-Head

Bigger by revenue
OPK
OPK
1.2× larger
OPK
$148.5M
$120.4M
HIPO
Growing faster (revenue YoY)
HIPO
HIPO
+37.3% gap
HIPO
18.2%
-19.2%
OPK
Higher net margin
HIPO
HIPO
26.0% more per $
HIPO
5.0%
-21.1%
OPK
More free cash flow
HIPO
HIPO
$37.7M more FCF
HIPO
$9.1M
$-28.6M
OPK
Faster 2-yr revenue CAGR
HIPO
HIPO
Annualised
HIPO
18.9%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
HIPO
HIPO
OPK
OPK
Revenue
$120.4M
$148.5M
Net Profit
$6.0M
$-31.3M
Gross Margin
43.1%
Operating Margin
5.6%
-25.8%
Net Margin
5.0%
-21.1%
Revenue YoY
18.2%
-19.2%
Net Profit YoY
-86.4%
-322.8%
EPS (diluted)
$0.31
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
HIPO
HIPO
OPK
OPK
Q4 25
$120.4M
$148.5M
Q3 25
$120.6M
$151.7M
Q2 25
$117.3M
$156.8M
Q1 25
$110.3M
$150.0M
Q4 24
$101.9M
$183.6M
Q3 24
$95.5M
$173.6M
Q2 24
$89.6M
$182.2M
Q1 24
$85.1M
$173.7M
Net Profit
HIPO
HIPO
OPK
OPK
Q4 25
$6.0M
$-31.3M
Q3 25
$98.1M
$21.6M
Q2 25
$1.3M
$-148.4M
Q1 25
$-47.7M
$-67.6M
Q4 24
$44.2M
$14.0M
Q3 24
$-8.5M
$24.9M
Q2 24
$-40.5M
$-10.3M
Q1 24
$-35.7M
$-81.8M
Gross Margin
HIPO
HIPO
OPK
OPK
Q4 25
43.1%
Q3 25
32.9%
Q2 25
31.5%
Q1 25
28.4%
Q4 24
46.1%
Q3 24
23.1%
Q2 24
28.4%
Q1 24
24.2%
Operating Margin
HIPO
HIPO
OPK
OPK
Q4 25
5.6%
-25.8%
Q3 25
81.3%
31.7%
Q2 25
3.4%
-38.3%
Q1 25
-41.3%
-44.8%
Q4 24
46.3%
-18.0%
Q3 24
-5.4%
8.2%
Q2 24
-40.7%
-33.9%
Q1 24
-38.7%
-41.2%
Net Margin
HIPO
HIPO
OPK
OPK
Q4 25
5.0%
-21.1%
Q3 25
81.3%
14.3%
Q2 25
1.1%
-94.7%
Q1 25
-43.2%
-45.1%
Q4 24
43.4%
7.6%
Q3 24
-8.9%
14.3%
Q2 24
-45.2%
-5.7%
Q1 24
-42.0%
-47.1%
EPS (diluted)
HIPO
HIPO
OPK
OPK
Q4 25
$0.31
$-0.04
Q3 25
$3.77
$0.03
Q2 25
$0.05
$-0.19
Q1 25
$-1.91
$-0.10
Q4 24
$1.81
$0.02
Q3 24
$-0.34
$0.03
Q2 24
$-1.64
$-0.01
Q1 24
$-1.47
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
HIPO
HIPO
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$218.3M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$436.1M
$1.3B
Total Assets
$1.9B
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
HIPO
HIPO
OPK
OPK
Q4 25
$218.3M
$364.4M
Q3 25
$247.7M
$412.0M
Q2 25
$198.9M
$267.3M
Q1 25
$140.9M
$428.8M
Q4 24
$197.6M
$426.6M
Q3 24
$191.2M
$400.1M
Q2 24
$175.9M
$40.6M
Q1 24
$223.4M
$75.6M
Total Debt
HIPO
HIPO
OPK
OPK
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
HIPO
HIPO
OPK
OPK
Q4 25
$436.1M
$1.3B
Q3 25
$421.5M
$1.3B
Q2 25
$332.5M
$1.3B
Q1 25
$322.8M
$1.3B
Q4 24
$362.1M
$1.4B
Q3 24
$326.4M
$1.4B
Q2 24
$322.6M
$1.4B
Q1 24
$351.2M
$1.3B
Total Assets
HIPO
HIPO
OPK
OPK
Q4 25
$1.9B
$1.9B
Q3 25
$1.9B
$2.0B
Q2 25
$1.7B
$2.0B
Q1 25
$1.5B
$2.1B
Q4 24
$1.5B
$2.2B
Q3 24
$1.5B
$2.3B
Q2 24
$1.5B
$2.0B
Q1 24
$1.5B
$2.0B
Debt / Equity
HIPO
HIPO
OPK
OPK
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
HIPO
HIPO
OPK
OPK
Operating Cash FlowLast quarter
$9.2M
$-25.9M
Free Cash FlowOCF − Capex
$9.1M
$-28.6M
FCF MarginFCF / Revenue
7.6%
-19.3%
Capex IntensityCapex / Revenue
0.1%
1.8%
Cash ConversionOCF / Net Profit
1.53×
TTM Free Cash FlowTrailing 4 quarters
$14.8M
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
HIPO
HIPO
OPK
OPK
Q4 25
$9.2M
$-25.9M
Q3 25
$16.9M
$-34.6M
Q2 25
$24.7M
$-83.4M
Q1 25
$-35.6M
$-34.6M
Q4 24
$47.5M
$-44.4M
Q3 24
$46.8M
$-77.1M
Q2 24
$-10.6M
$-26.4M
Q1 24
$17.7M
$-35.6M
Free Cash Flow
HIPO
HIPO
OPK
OPK
Q4 25
$9.1M
$-28.6M
Q3 25
$16.8M
$-37.8M
Q2 25
$24.6M
$-86.7M
Q1 25
$-35.7M
$-37.7M
Q4 24
$47.2M
$-49.8M
Q3 24
$-85.0M
Q2 24
$-10.7M
$-33.7M
Q1 24
$17.6M
$-40.0M
FCF Margin
HIPO
HIPO
OPK
OPK
Q4 25
7.6%
-19.3%
Q3 25
13.9%
-24.9%
Q2 25
21.0%
-55.3%
Q1 25
-32.4%
-25.2%
Q4 24
46.3%
-27.1%
Q3 24
-49.0%
Q2 24
-11.9%
-18.5%
Q1 24
20.7%
-23.0%
Capex Intensity
HIPO
HIPO
OPK
OPK
Q4 25
0.1%
1.8%
Q3 25
0.1%
2.1%
Q2 25
0.1%
2.1%
Q1 25
0.1%
2.1%
Q4 24
0.3%
2.9%
Q3 24
0.0%
4.6%
Q2 24
0.1%
4.0%
Q1 24
0.1%
2.6%
Cash Conversion
HIPO
HIPO
OPK
OPK
Q4 25
1.53×
Q3 25
0.17×
-1.60×
Q2 25
19.00×
Q1 25
Q4 24
1.07×
-3.17×
Q3 24
-3.10×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

HIPO
HIPO

Segment breakdown not available.

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons